Myriad Genetics, Inc. - Common Stock (NQ:MYGN)
Price and Volume
Detailed Quote| Volume | 706,747 |
| Open | 4.240 |
| Bid (Size) | 4.200 (2,000) |
| Ask (Size) | 4.210 (800) |
| Prev. Close | 4.280 |
| Today's Range | 4.050 - 4.255 |
| 52wk Range | 2.740 - 8.590 |
| Shares Outstanding | 93,500,000 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
51.0% below 52-week high
4.205
2.7452W Low
8.5952W High
1 Week
12.9% below 1-week high
4.051W Low
4.831W High
Myriad Genetics, Inc. - Common Stock (MYGN) traded between $2.74 and $8.59 over the past 52 weeks and last traded at $4.21, 51.0% below its 52-week high. Over the past week it ranged between $4.05 and $4.83.
Past 12 Months
1W
+$0.15
1M
+$1.02
3M
-$1.67
6M
-$0.56
YTD
-$1.93
1Y
-$3.33
MYGN was -44.2% over the past year, -11.8% over six months, -31.5% year to date, +3.6% in the last week.
12 Months vs Market
MYGN
-44.2%
DIA
+9.7%
SPY
+15.5%
QQQ
+23.4%
IWM
+13.5%
Over the past 12 months MYGN returned -44.2% versus DIA (Dow) +9.7%, SPY (S&P 500) +15.5%, QQQ (Nasdaq 100) +23.4% and IWM (Russell 2000) +13.5%.
Volume & Liquidity
0.35× 3-mo avg
Today 706,747
3-mo avg 2.0M
1W
2.0M
1M
2.2M
3M
2.0M
6M
1.8M
YTD
1.8M
1Y
1.6M
MYGN most recently traded 706,747 shares against a 3-month average daily volume of 2.0M.
More News
Read More
Why Is Myriad Genetics (MYGN) Stock Soaring Today
October 02, 2026
1 Volatile Stock on Our Buy List and 2 We Question
October 02, 2026
3 Reasons MYGN is Risky and 1 Stock to Buy Instead
September 24, 2026
Reflecting On Therapeutics Stocks’ Q2 Earnings: AbbVie (NYSE:ABBV)
September 21, 2026
1 Unpopular Stock That Deserves Some Love and 2 We Turn Down
September 17, 2026
Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial
September 16, 2026
2 Unprofitable Stocks to Research Further and 1 We Find Risky
September 15, 2026
Therapeutics Stocks Q2 Recap: Benchmarking Myriad Genetics (NASDAQ:MYGN)
September 07, 2026
Why Myriad Genetics (MYGN) Stock Is Down Today
September 01, 2026
1 Small-Cap Stock with Promising Prospects and 2 That Underwhelm
August 18, 2026
Q2 Rundown: Natera (NASDAQ:NTRA) Vs Other Biotechnology Stocks
August 17, 2026
3 Healthcare Stocks with Open Questions
August 10, 2026
Myriad Genetics Q2 Earnings Call Highlights ↗
July 31, 2026
Top movers in Friday's session ↗
July 31, 2026
Frequently Asked Questions
Is Myriad Genetics, Inc. - Common Stock publicly traded?
Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
What exchange does Myriad Genetics, Inc. - Common Stock trade on?
Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
What is the current price of Myriad Genetics, Inc. - Common Stock?
The current price of Myriad Genetics, Inc. - Common Stock is 4.205
When was Myriad Genetics, Inc. - Common Stock last traded?
The last trade of Myriad Genetics, Inc. - Common Stock was at 10/08/26 03:16 PM ET
What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
The market capitalization of Myriad Genetics, Inc. - Common Stock is 393.17M
How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
Myriad Genetics, Inc. - Common Stock has 393M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Copyright 2024. BUSINESS INSURANCE HOLDINGS
